Rockefeller Capital Management
VNDA icon

Rockefeller Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Rockefeller Capital Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.89K Sell
472
-652
-58% -$4.26K ﹤0.01% 4351
2026
Q1 		$7.77K Buy
1,124
+924
+462% +$7.13K ﹤0.01% 4097
2025
Q4 		$1.76K Buy
+200
New +$1.1K ﹤0.01% 4353
2023
Q1 		– Sell
-40
Closed – – 3832
2022
Q4 		$0 Hold
40
– – ﹤0.01% 4237
2022
Q3 		$0 Sell
40
-31
-44% -$327 ﹤0.01% 4410
2022
Q2 		$0 Sell
71
-52
-42% -$539 ﹤0.01% 4413
2022
Q1 		$1K Sell
123
-581
-83% -$7.64K ﹤0.01% 3791
2021
Q4 		$11K Buy
704
+504
+252% +$8.78K ﹤0.01% 2948
2021
Q3 		$3K Hold
200
– – ﹤0.01% 3368
2021
Q2 		$4K Buy
+200
New +$3.58K ﹤0.01% 3114
2021
Q1 		– Sell
-500
Closed -$6K – 3401
2020
Q4 		$6K Hold
500
– – ﹤0.01% 2402
2020
Q3 		$4K Sell
500
-59
-11% -$631 ﹤0.01% 2306
2020
Q2 		$6K Sell
559
-109
-16% -$1.23K ﹤0.01% 2063
2020
Q1 		$7K Hold
668
– – ﹤0.01% 1868
2019
Q4 		$11K Buy
668
+133
+25% +$2.01K ﹤0.01% 1595
2019
Q3 		$7K Sell
535
-35
-6% -$488 ﹤0.01% 1544
2019
Q2 		$8K Sell
570
-370
-39% -$5.89K ﹤0.01% 1331
2019
Q1 		$17K Buy
+940
New +$21.4K ﹤0.01% 1316

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rockefeller Capital Management's VNDA Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Vanda Pharmaceuticals (VNDA) stake by 58% in Q2 2026, selling an estimated $4.26K and leaving 472 shares worth $2.89K. The position accounts for ﹤0.01% of the portfolio, ranked #4351.

Rockefeller Capital Management first reported a position in VNDA in Q1 2019 and has held it in 18 quarters since. The position peaked at $17K in Q1 2019. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Rockefeller Capital Management held 472 shares of Vanda Pharmaceuticals worth $2.89K as of Q2 2026.
  • Rockefeller Capital Management sold 652 Vanda Pharmaceuticals shares in Q2 2026, an estimated $4.26K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4351 holding.
  • Rockefeller Capital Management first reported a position in Vanda Pharmaceuticals in Q1 2019 and has held it in 18 quarters since.
  • Rockefeller Capital Management's Vanda Pharmaceuticals position peaked at $17K in Q1 2019.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.